\-\ Texto\\:\\ \ \(0\)\
\-\ post\\ ictal\\.\ \(0\)\
\-\ negative\\ laboratory\\ evaluation\\ \\-\\ including\\ csf\\ analysis\ \(0\)\
\-\ patient\\ rapidly\\ improved\\ with\\ steroids\\ and\\ anitconvulsant\\ therapy\\.\\ \\ patient\\ and\\ mri\\ three\\ months\\ later\\ are\\ completely\\ normal\\.\ \(0\)\
\-\ diffuse\\ supratentorial\\ deep\\ white\\ matter\\ changes\\,\\ without\\ mass\\ effect\\ of\\ enhancement\\.\ \(0\)\
\-\ acute\\ disseminated\\ encephalomyelitis\ \(7\)\
\-\ \\â\\€\\¢\\ acute\\ disseminated\\ encephalomyelitis\\ \\(adem\\)\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ pres\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ sclerosis\ \(0\)\
\-\ 3\\ year\\ old\\ girl\\ with\\ recurrence\\ of\\ abdominal\\ pain\\ and\\ dysuria\\ upon\\ completion\\ of\\ a\\ 10\\ day\\ course\\ of\\ antibiotics\\ for\\ cystitis\\.\\ \\ parents\\ found\\ her\\ in\\ bed\\ having\\ a\\ seizure\\ the\\ next\\ morning\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ encephalomyelitis\\:\\ 0\\.33222264591152456\ \(0\)\
\-\ disseminated\\:\\ 0\\.3072522860387843\ \(0\)\
\-\ anitconvulsant\\:\\ 0\\.2268435107160959\ \(0\)\
\-\ ictal\\:\\ 0\\.18029867510856967\ \(0\)\
\-\ pres\\:\\ 0\\.175135447808956\ \(0\)\
\-\ cystitis\\:\\ 0\\.16721667479628052\ \(0\)\
\-\ completion\\:\\ 0\\.16611132295576228\ \(0\)\
\-\ dysuria\\:\\ 0\\.16212419099239525\ \(0\)\
\-\ supratentorial\\:\\ 0\\.16121986144290815\ \(0\)\
\-\ acute\\:\\ 0\\.15346711900358717\ \(0\)\
\-\ adem\\:\\ 0\\.15235066744590559\ \(0\)\
\-\ parents\\:\\ 0\\.14781700091137356\ \(0\)\
\-\ bed\\:\\ 0\\.14730427507686028\ \(0\)\
\-\ rapidly\\:\\ 0\\.14185721857300085\ \(0\)\
\-\ morning\\:\\ 0\\.14066340587086273\ \(0\)\
\-\ next\\:\\ 0\\.1324636544790494\ \(0\)\
\-\ analysis\\:\\ 0\\.13191104680442853\ \(0\)\
\-\ completely\\:\\ 0\\.12674781950481487\ \(0\)\
\-\ improved\\:\\ 0\\.12587522744780041\ \(0\)\
\-\ steroids\\:\\ 0\\.12462119760395421\ \(0\)\
\-\ having\\:\\ 0\\.12228827022925864\ \(0\)\
\-\ seizure\\:\\ 0\\.11803452772367767\ \(0\)\
\-\ recurrence\\:\\ 0\\.11711344753564766\ \(0\)\
\-\ csf\\:\\ 0\\.11208243798303891\ \(0\)\
\-\ upon\\:\\ 0\\.11159484742002458\ \(0\)\
\-\ of\\:\\ 0\\.11103496658992965\ \(0\)\
\-\ deep\\:\\ 0\\.11041612808525533\ \(0\)\
\-\ matter\\:\\ 0\\.10800428716996499\ \(0\)\
\-\ course\\:\\ 0\\.10477544133340705\ \(0\)\
\-\ antibiotics\\:\\ 0\\.10450168089522252\ \(0\)\
\-\ laboratory\\:\\ 0\\.10300484864574261\ \(0\)\
\-\ including\\:\\ 0\\.10151242149148879\ \(0\)\
\-\ later\\:\\ 0\\.10151242149148879\ \(0\)\
\-\ sclerosis\\:\\ 0\\.10103420825373943\ \(0\)\
\-\ effect\\:\\ 0\\.09950348986620818\ \(0\)\
\-\ girl\\:\\ 0\\.09950348986620818\ \(0\)\
\-\ three\\:\\ 0\\.09521848862366779\ \(0\)\
\-\ white\\:\\ 0\\.09358633377895861\ \(0\)\
\-\ patient\\:\\ 0\\.0922711225679608\ \(0\)\
\-\ found\\:\\ 0\\.0917811824818097\ \(0\)\
\-\ day\\:\\ 0\\.09035381790741849\ \(0\)\
\-\ diffuse\\:\\ 0\\.08895534296372284\ \(0\)\
\-\ her\\:\\ 0\\.08861767675894752\ \(0\)\
\-\ and\\:\\ 0\\.08793255771740664\ \(0\)\
\-\ negative\\:\\ 0\\.08781622829116537\ \(0\)\
\-\ evaluation\\:\\ 0\\.08650598274420658\ \(0\)\
\-\ changes\\:\\ 0\\.08572613870144473\ \(0\)\
\-\ lymphoma\\:\\ 0\\.08447840262417992\ \(0\)\
\-\ 10\\:\\ 0\\.08294465718489907\ \(0\)\
\-\ months\\:\\ 0\\.08256616704703211\ \(0\)\
\-\ enhancement\\:\\ 0\\.08164440391529139\ \(0\)\
\-\ therapy\\:\\ 0\\.08150004169863954\ \(0\)\
\-\ abdominal\\:\\ 0\\.0775796399223151\ \(0\)\
\-\ post\\:\\ 0\\.07718323399764009\ \(0\)\
\-\ without\\:\\ 0\\.07481872116916376\ \(0\)\
\-\ mri\\:\\ 0\\.07281143180666991\ \(0\)\
\-\ multiple\\:\\ 0\\.06938023389368644\ \(0\)\
\-\ normal\\:\\ 0\\.05791499452554249\ \(0\)\
\-\ with\\:\\ 0\\.05555065497800448\ \(0\)\
\-\ mass\\:\\ 0\\.054181594801057095\ \(0\)\
\-\ are\\:\\ 0\\.05382431391368024\ \(0\)\
\-\ pain\\:\\ 0\\.050757915098845516\ \(0\)\
\-\ year\\:\\ 0\\.04371431344705748\ \(0\)\
\-\ for\\:\\ 0\\.04299260014410156\ \(0\)\
\-\ old\\:\\ 0\\.04198087299430141\ \(0\)\
\-\ in\\:\\ 0\\.035286817697494345\ \(0\)\
\-\ the\\:\\ 0\\.028303526136255978\ \(0\)\
